This research study aims to evaluate the safety and effectiveness of a novel immunotherapy, Fast TIL, an Adoptive Cellular Therapeutic (ACT), to fight cancer t…

Malignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more

~Estimated

~$10 – $7,500

David Bartlett, MDNCT07192900

Phase 1

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors: A Phase I Trial (FAST TILS 2)

This research study aims to evaluate the safety and effectiveness of a novel immunotherapy, Fast TIL, an Adoptive Cellular Therapeutic (ACT), to fight cancer t…

Malignant Pleural EffusionMalignant MesotheliomaPleural Effusion, Malignant+1 more

~Estimated

~$10 – $7,500

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT07443020